Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis.
Burmistrova DA, Tillib SV, Shcheblyakov DV, Dolzhikova IV, Shcherbinin DN, Zubkova OV, Ivanova TI, Tukhvatulin AI, Shmarov MM, Logunov DY, Naroditsky BS, Gintsburg AL. Burmistrova DA, et al. Among authors: gintsburg al. PLoS One. 2016 Mar 10;11(3):e0150958. doi: 10.1371/journal.pone.0150958. eCollection 2016. PLoS One. 2016. PMID: 26962869 Free PMC article.
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection.
Voronina DV, Shcheblyakov DV, Favorskaya IA, Esmagambetov IB, Dzharullaeva AS, Tukhvatulin AI, Zubkova OV, Popova O, Kan VY, Bandelyuk AS, Shmarov MM, Logunov DY, Naroditskiy BS, Gintsburg AL. Voronina DV, et al. Among authors: gintsburg al. Viruses. 2022 Nov 10;14(11):2485. doi: 10.3390/v14112485. Viruses. 2022. PMID: 36366583 Free PMC article.
Resistance of THP-1 Leukemia Cells Infected with Cytomegalovirus to Anti-tumor Antibiotic Doxorubicin and Restoration of the Sensitivity by Inhibitors of the PI3K/AKT/mTOR Molecular Pathway.
Chernoryzh YY, Fedorova NE, Yurlov KI, Simonov RA, Kornev AB, Karpov DS, Zakirova NF, Ivanov AV, Kushch AA, Gintsburg AL. Chernoryzh YY, et al. Among authors: gintsburg al. Dokl Biochem Biophys. 2019 Nov;489(1):388-391. doi: 10.1134/S1607672919060073. Epub 2020 Mar 4. Dokl Biochem Biophys. 2019. PMID: 32130607
Current Trends of HIV Infection in the Russian Federation.
Ogarkova D, Antonova A, Kuznetsova A, Adgamov R, Pochtovyi A, Kleimenov D, Tsyganova E, Gushchin V, Gintsburg A, Mazus A. Ogarkova D, et al. Viruses. 2023 Oct 26;15(11):2156. doi: 10.3390/v15112156. Viruses. 2023. PMID: 38005834 Free PMC article.
Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus.
Shcheblyakov DV, Voronina DV, Favorskaya IA, Esmagambetov IB, Alekseeva IA, Korobkova AI, Ryabova EI, Derkaev AA, Kan VY, Dzharullaeva AS, Tukhvatulin AI, Bandelyuk AS, Shmarov MM, Logunov DY, Gintsburg AL. Shcheblyakov DV, et al. Among authors: gintsburg al. Acta Naturae. 2024 Jan-Mar;16(1):101-110. doi: 10.32607/actanaturae.27374. Acta Naturae. 2024. PMID: 38698957 Free PMC article.
Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response.
Mazunina EP, Gushchin VA, Kleymenov DA, Siniavin AE, Burtseva EI, Shmarov MM, Mukasheva EA, Bykonia EN, Kozlova SR, Evgrafova EA, Zolotar AN, Shidlovskaya EV, Kirillova ES, Krepkaia AS, Usachev EV, Kuznetsova NA, Ivanov IA, Dmitriev SE, Ivanov RA, Logunov DY, Gintsburg AL. Mazunina EP, et al. Among authors: gintsburg al. Front Immunol. 2024 Apr 16;15:1381508. doi: 10.3389/fimmu.2024.1381508. eCollection 2024. Front Immunol. 2024. PMID: 38690272 Free PMC article.
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins.
Bykonia EN, Kleymenov DA, Gushchin VA, Siniavin AE, Mazunina EP, Kozlova SR, Zolotar AN, Usachev EV, Kuznetsova NA, Shidlovskaya EV, Pochtovyi AA, Kustova DD, Ivanov IA, Dmitriev SE, Ivanov RA, Logunov DY, Gintsburg AL. Bykonia EN, et al. Among authors: gintsburg al. Vaccines (Basel). 2024 Apr 2;12(4):379. doi: 10.3390/vaccines12040379. Vaccines (Basel). 2024. PMID: 38675761 Free PMC article.
New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses.
Siniavin AE, Gushchin VA, Shastina NS, Darnotuk ES, Luyksaar SI, Russu LI, Inshakova AM, Shidlovskaya EV, Vasina DV, Kuznetsova NA, Savina DM, Zorkov ID, Dolzhikova IV, Sheremet AB, Logunov DY, Zigangirova NA, Gintsburg AL. Siniavin AE, et al. Among authors: gintsburg al. Antiviral Res. 2024 May;225:105871. doi: 10.1016/j.antiviral.2024.105871. Epub 2024 Mar 28. Antiviral Res. 2024. PMID: 38555022 Free article.
Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses.
Darnotuk ES, Siniavin AE, Shastina NS, Luyksaar SI, Inshakova AM, Bondareva NE, Zolotov SA, Lubenec NL, Sheremet AB, Logunov DY, Zigangirova NA, Gushchin VA, Gintsburg AL. Darnotuk ES, et al. Among authors: gintsburg al. Pharmaceuticals (Basel). 2023 Dec 26;17(1):35. doi: 10.3390/ph17010035. Pharmaceuticals (Basel). 2023. PMID: 38256869 Free PMC article.
274 results